1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Rehabilitation Robots Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Rehabilitation Robots Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Regulatory Scenario by Region/Globally
5.3. Pipeline Analysis
5.4. Disease Prevalence & Incidence Rate Globally With Key Countries
5.5. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Rehabilitation Robots Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2017-2031
6.3.1. Therapeutic Robots
6.3.2. Exoskeleton
6.3.3. Assistive Robots
6.3.4. Others
6.4. Market Attractiveness Analysis, by Type
7. Global Rehabilitation Robots Market Analysis and Forecast, by Patient Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Patient Type, 2017-2031
7.3.1. Mentally-ill
7.3.2. Disabled
7.3.3. Pediatrics
7.4. Market Attractiveness Analysis, by Patient Type
8. Global Rehabilitation Robots Market Analysis and Forecast, by Extremity Analysis
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Extremity Analysis, 2017-2031
8.3.1. Upper Body
8.3.2. Lower Body
8.4. Market Attractiveness Analysis, by Extremity Analysis
9. Global Rehabilitation Robots Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Hospitals
9.3.2. Rehabilitation Centers
9.3.3. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Rehabilitation Robots Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017-2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America Rehabilitation Robots Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017-2031
11.2.1. Therapeutic Robots
11.2.2. Exoskeleton
11.2.3. Assistive Robots
11.2.4. Others
11.3. Market Value Forecast, by Patient Type, 2017-2031
11.3.1. Mentally-ill
11.3.2. Disabled
11.3.3. Pediatrics
11.4. Market Value Forecast, by Extremity Analysis, 2017-2031
11.4.1. Upper Body
11.4.2. Lower Body
11.5. Market Value Forecast, by End-user, 2017-2031
11.5.1. Hospitals
11.5.2. Rehabilitation Centers
11.5.3. Others
11.6. Market Value Forecast, by Country, 2017-2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Patient Type
11.7.3. By Extremity Analysis
11.7.4. By End-user
11.7.5. By Country
12. Europe Rehabilitation Robots Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017-2031
12.2.1. Therapeutic Robots
12.2.2. Exoskeleton
12.2.3. Assistive Robots
12.2.4. Others
12.3. Market Value Forecast, by Patient Type, 2017-2031
12.3.1. Mentally-ill
12.3.2. Disabled
12.3.3. Pediatrics
12.4. Market Value Forecast, by Extremity Analysis, 2017-2031
12.4.1. Upper Body
12.4.2. Lower Body
12.5. Market Value Forecast, by End-user, 2017-2031
12.5.1. Hospitals
12.5.2. Rehabilitation Centers
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Patient Type
12.7.3. By Extremity Analysis
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Rehabilitation Robots Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017-2031
13.2.1. Therapeutic Robots
13.2.2. Exoskeleton
13.2.3. Assistive Robots
13.2.4. Others
13.3. Market Value Forecast, by Patient Type, 2017-2031
13.3.1. Mentally-ill
13.3.2. Disabled
13.3.3. Pediatrics
13.4. Market Value Forecast, by Extremity Analysis, 2017-2031
13.4.1. Upper Body
13.4.2. Lower Body
13.5. Market Value Forecast, by End-user, 2017-2031
13.5.1. Hospitals
13.5.2. Rehabilitation Centers
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Patient Type
13.7.3. By Extremity Analysis
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Rehabilitation Robots Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017-2031
14.2.1. Therapeutic Robots
14.2.2. Exoskeleton
14.2.3. Assistive Robots
14.2.4. Others
14.3. Market Value Forecast, by Patient Type, 2017-2031
14.3.1. Mentally-ill
14.3.2. Disabled
14.3.3. Pediatrics
14.4. Market Value Forecast, by Extremity Analysis, 2017-2031
14.4.1. Upper Body
14.4.2. Lower Body
14.5. Market Value Forecast, by End-user, 2017-2031
14.5.1. Hospitals
14.5.2. Rehabilitation Centers
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Patient Type
14.7.3. By Extremity Analysis
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Rehabilitation Robots Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2017-2031
15.2.1. Therapeutic Robots
15.2.2. Exoskeleton
15.2.3. Assistive Robots
15.2.4. Others
15.3. Market Value Forecast, by Patient Type, 2017-2031
15.3.1. Mentally-ill
15.3.2. Disabled
15.3.3. Pediatrics
15.4. Market Value Forecast, by Extremity Analysis, 2017-2031
15.4.1. Upper Body
15.4.2. Lower Body
15.5. Market Value Forecast, by End-user, 2017-2031
15.5.1. Hospitals
15.5.2. Rehabilitation Centers
15.5.3. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Type
15.7.2. By Patient Type
15.7.3. By Extremity Analysis
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix, by tier and size of companies
16.2. Market Share Analysis, by Company, 2022
16.3. Company Profiles
16.3.1. Bionik Laboratories Corporation
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Cyberdyne, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Ekso Bionics Holdings, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. ReWalk Robotics Ltd.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Hocoma AG (DIH International Ltd.)
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Rehab-Robotics Company Limited
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Kinova, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Rex Bionics Ltd.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Life Science Robotics ApS
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Tyromotion GmbH
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
